Overview
Westlake Chemical Q3 revenue missed analyst expectations
Net income for Q3 2025 decreased compared to Q3 2024
Company renewed Ethylene Sales Agreement through 2027 at existing terms
Outlook
Company renewed Ethylene Sales Agreement through 2027 at existing terms
Result Drivers
ETHYLENE SALES AGREEMENT - Stable cash flows maintained despite declining spot ethylene prices due to Ethylene Sales Agreement
HIGHER MAINTENANCE EXPENSES - Decrease in MLP distributable cash flow due to higher maintenance capital expenditures
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Revenue | Miss | $276.54 mln | $303 mln (1 Analyst) |
Q3 EPS | $0.42 | ||
Q3 Net Income | $86.21 mln | ||
Q3 EBITDA | $126.07 mln | ||
Q3 Gross Profit | $99.42 mln | ||
Q3 Income from Operations | $91.97 mln |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the commodity chemicals peer group is "buy"
Wall Street's median 12-month price target for Westlake Chemical Partners LP is $25.50, about 25.7% above its October 29 closing price of $18.95
The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 12 three months ago
Press Release: ID:nBw1cjWqWa
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)